GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hanall Biopharma Co 009420.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

37,100

+3.92%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hanall Biopharma Co

Its shares trade on KRX under the ticker 009420.KS. It has been listed since 18 December 1989. In the fiscal year to 31 December 2025, it reported revenue of ₩155.18bn and a net loss of ₩5.56bn. At that date it held total assets of ₩225.22bn and shareholders' equity of ₩161.68bn.

HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. The company is headquartered in Daejeon, Daejeon. The firm mainly manufactures and sells pharmaceutical products including antidiabetic drugs, skin drugs, muscle relaxants, hepatitis drugs, digestion drugs, anti-cardiovascular drugs, neurologic drugs, interferons, antiviral drugs, antibiotics, antihistamine, anti-inflammatory drugs, and others. The firm also engages in the leasing of real estates. The firm distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
18 Dec 1989

Leadership

Pay as last reported

  • Mr. Jae Chun YoonChairman
  • Mr. Seung Won JungCo-Chief Executive Officer, Director
  • Mr. Su Jin ParkCo-Chief Executive Officer, Director, since 2023
  • Seong Wun KimAssistant Managing Director
  • Mr. Seung Guk ParkDirector, since 2011
  • Mr. Heon JungNon-Executive Independent Director
  • Mr. Han Ju KimNon-Executive Independent Director
  • Mr. Cheol Heon LeeNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.